Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome

被引:18
作者
Heubner, Lars [1 ]
Petrick, Paul Leon [1 ]
Gueldner, Andreas [1 ]
Bartels, Lea [1 ]
Ragaller, Maximillian [1 ]
Mirus, Martin [1 ]
Rand, Axel [1 ]
Tiebel, Oliver [2 ]
Beyer-Westendorf, Jan [3 ]
Roessler, Martin [4 ,5 ]
Schmitt, Jochen [4 ,5 ]
Koch, Thea [1 ]
Spieth, Peter Markus [1 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care Med, Dresden, Germany
[2] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Inst Clin Chem, Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med Thrombosis Res 1, Div Hematol & Hemostasis, Dresden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare ZEGV, Dresden, Germany
[5] Tech Univ Dresden, Carl Gustav Carus Fac Med, Dresden, Germany
关键词
EXTRACORPOREAL MEMBRANE-OXYGENATION; HEMATOLOGY; 2021; GUIDELINES; QUALITY-OF-LIFE; INTENSIVE-CARE; PLASMINOGEN-ACTIVATOR; CYTOKINE ADSORPTION; AMERICAN SOCIETY; SOFA SCORE; SEPSIS; ANTICOAGULATION;
D O I
10.1038/s41598-022-22107-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acute Respiratory Distress Syndrome (ARDS) is common in COVID-19 patients and is associated with high mortality. The aim of this observational study was to describe patients' characteristics and outcome, identifying potential risk factors for in-hospital mortality and for developing Long-COVID symptoms. This retrospective study included all patients with COVID-19 associated ARDS (cARDS) in the period from March 2020 to March 2021 who were invasively ventilated at the intensive care unit (ICU) of the University Hospital Dresden, Germany. Between October 2021 and December 2021 patients discharged alive (at minimum 6 months after hospital discharge-midterm survival) were contacted and interviewed about persistent symptoms possibly associated with COVID-19 as well as the quality of their lives using the EQ-5D-5L-questionnaire. Long-COVID was defined as the occurrence of one of the symptoms at least 6 months after discharge. Risk factors for mortality were assessed with Cox regression models and risk factors for developing Long-COVID symptoms by using relative risk (RR) regression. 184 Patients were included in this study (male: n = 134 (73%), median age 67 (range 25-92). All patients were diagnosed with ARDS according to the Berlin Definition. 89% of patients (n = 164) had severe ARDS (Horovitz-index < 100 mmHg). In 27% (n = 49) extracorporeal membrane oxygenation was necessary to maintain gas exchange. The median length of in-hospital stay was 19 days (range 1-60). ICU mortality was 51%, hospital mortality 59%. Midterm survival (median 11 months) was 83% (n = 55) and 78% (n = 43) of these patients presented Long-COVID symptoms with fatigue as the most common symptom (70%). Extreme obesity (BMI > 40 kg/m(2)) was the strongest predictor for in-hospital mortality (hazard ratio: 3.147, confidence interval 1.000-9.897) and for developing Long-COVID symptoms (RR 1.61, confidence interval 1.26-2.06). In-hospital mortality in severe cARDS patients was high, but > 80% of patients discharged alive survived the midterm observation period. Nonetheless, most patients developed Long-COVID symptoms. Extreme obesity with BMI > 40 kg/m(2) was identified as independent risk factor for in-hospital mortality and for developing Long-COVID symptoms.
引用
收藏
页数:16
相关论文
共 74 条
[1]   The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management [J].
Abou-Ismail, Mouhamed Yazan ;
Diamond, Akiva ;
Kapoor, Sargam ;
Arafah, Yasmin ;
Nayak, Lalitha .
THROMBOSIS RESEARCH, 2020, 194 :101-115
[2]   Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 [J].
Ackermann, Maximilian ;
Verleden, Stijn E. ;
Kuehnel, Mark ;
Haverich, Axel ;
Welte, Tobias ;
Laenger, Florian ;
Vanstapel, Arno ;
Werlein, Christopher ;
Stark, Helge ;
Tzankov, Alexandar ;
Li, William W. ;
Li, Vincent W. ;
Mentzer, Steven J. ;
Jonigk, Danny .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (02) :120-128
[3]   Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19 [J].
Al-Samkari, Hanny ;
Gupta, Shruti ;
Leaf, Rebecca Karp ;
Wang, Wei ;
Rosovsky, Rachel P. ;
Brenner, Samantha K. ;
Hayek, Salim S. ;
Berlin, Hanna ;
Kapoor, Rajat ;
Shaefi, Shahzad ;
Melamed, Michal L. ;
Sutherland, Anne ;
Radbel, Jared ;
Green, Adam ;
Garibaldi, Brian T. ;
Srivastava, Anand ;
Leonberg-Yoo, Amanda ;
Shehata, Alexandre M. ;
Flythe, Jennifer E. ;
Rashidi, Arash ;
Goyal, Nitender ;
Chan, Lili ;
Mathews, Kusum S. ;
Hedayati, S. Susan ;
Dy, Rajany ;
Toth-Manikowski, Stephanie M. ;
Zhang, Jingjing ;
Mallappallil, Mary ;
Redfern, Roberta E. ;
Bansal, Amar D. ;
Short, Samuel A. P. ;
Vangel, Mark G. ;
Admon, Andrew J. ;
Semler, Matthew W. ;
Bauer, Kenneth A. ;
Hernan, Miguel A. ;
Leaf, David E. .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (05) :622-+
[4]   Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update [J].
Alhazzani, Waleed ;
Evans, Laura ;
Alshamsi, Fayez ;
Moller, Morten Hylander ;
Ostermann, Marlies ;
Prescott, Hallie C. ;
Arabi, Yaseen M. ;
Loeb, Mark ;
Gong, Michelle Ng ;
Fan, Eddy ;
Oczkowski, Simon ;
Levy, Mitchell M. ;
Derde, Lennie ;
Dzierba, Amy ;
Du, Bin ;
Machado, Flavia ;
Wunsch, Hannah ;
Crowther, Mark ;
Cecconi, Maurizio ;
Koh, Younsuck ;
Burry, Lisa ;
Chertow, Daniel S. ;
Szczeklik, Wojciech ;
Belley-Cote, Emilie ;
Greco, Massimiliano ;
Bala, Malgorzata ;
Zarychanski, Ryan ;
Kesecioglu, Jozef ;
McGeer, Allison ;
Mermel, Leonard ;
Mammen, Manoj J. ;
Myatra, Sheila Nainan ;
Arrington, Amy ;
Kleinpell, Ruth ;
Citerio, Giuseppe ;
Lewis, Kimberley ;
Bridges, Elizabeth ;
Memish, Ziad A. ;
Hammond, Naomi ;
Hayden, Frederick G. ;
Alshahrani, Muhammed ;
Al Duhailib, Zainab ;
Martin, Greg S. ;
Kaplan, Lewis J. ;
Coopersmith, Craig M. ;
Antonelli, Massimo ;
Rhodes, Andrew .
CRITICAL CARE MEDICINE, 2021, 49 (03) :E219-E234
[5]  
[Anonymous], 2020, WHO COVID 19 DASHBOA
[6]   Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies [J].
Armstrong, R. A. ;
Kane, A. D. ;
Cook, T. M. .
ANAESTHESIA, 2020, 75 (10) :1340-1349
[7]  
Asadi-Pooya AA, 2021, IRAN J MED SCI, V46, P428, DOI 10.30476/ijms.2021.92080.2326
[8]   Impaired fibrinolysis in critically ill COVID-19 patients [J].
Bachler, Mirjam ;
Boesch, Johannes ;
Stuerzel, Daniel P. ;
Hell, Tobias ;
Giebl, Andreas ;
Stroehle, Mathias ;
Klein, Sebastian J. ;
Schaefer, Volker ;
Lehner, Georg F. ;
Joannidis, Michael ;
Thome, Claudius ;
Fries, Dietmar .
BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (03) :590-598
[9]   Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry [J].
Barbaro, Ryan P. ;
MacLaren, Graeme ;
Boonstra, Philip S. ;
Iwashyna, Theodore J. ;
Slutsky, Arthur S. ;
Fan, Eddy ;
Bartlett, Robert H. ;
Tonna, Joseph E. ;
Hyslop, Robert ;
Fanning, Jeffrey J. ;
Rycus, Peter T. ;
Hyer, Steve J. ;
Anders, Marc M. ;
Agerstrand, Cara L. ;
Hryniewicz, Katarzyna ;
Diaz, Rodrigo ;
Lorusso, Roberto ;
Combes, Alain ;
Brodie, Daniel .
LANCET, 2020, 396 (10257) :1071-1078
[10]   Extracorporeal Membrane Oxygenation for ARDS in Adults [J].
Brodie, Daniel ;
Bacchetta, Matthew .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1905-1914